Fate Therapeutics Reports Third Quarter 2022 Financial Results and Highlights Operational Progress
USA Life Sciences Database,
FT596+R Enrollment Ongoing in Three-dose Escalation Cohort for R/R BCL; Activating Community Sites for Investigation of FT596+R-C…